Ad is loading...
JVMCX vs MVTRX
JVMCX vs MVTRX Comparison
Open Charts JVMCX vs MVTRX
JHancock Disciplined Value Mid Cap C
Price$24.93
Change+$0.11 (+0.44%)
VolumeN/A
Net Assets21.11B
Transamerica Mid Cap Value Opps R6
Price$10.98
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets1.07B
JVMCX vs MVTRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
JVMCX vs. MVTRX commentary
Apr 03, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMCX is a Buy and MVTRX is a Buy.
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 21.1B vs. MVTRX (1.07B). MVTRX pays higher dividends than JVMCX: MVTRX (1.50) vs JVMCX (0.00). JVMCX was incepted earlier than MVTRX: JVMCX (14 years) vs MVTRX (9 years). JVMCX (1.88) is less costly to investors than MVTRX (0.74). MVTRX (48.00) and JVMCX (47.00) have comparable annual turnover. MVTRX has a lower initial minimum investment than JVMCX: MVTRX (0) vs JVMCX (1000). MVTRX annual gain was more profitable for investors over the last year : -4.55 vs. JVMCX (-11.29). JVMCX return over 5 years is better than : 74.69 vs. MVTRX (48.81).
| JVMCX | MVTRX | JVMCX / MVTRX | |
| Total Expense Ratio | 1.87 | 0.74 | 253% |
| Annual Report Gross Expense Ratio | 1.88 | 0.74 | 254% |
| Fund Existence | 14 years | 9 years | - |
| Gain YTD | -1.897 | 2.140 | -89% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 21.1B | 1.07B | 1,968% |
| Annual Yield % from dividends | 0.00 | 1.50 | - |
| Returns for 1 year | -11.29 | -4.55 | 248% |
| Returns for 3 years | -5.25 | -8.49 | 62% |
| Returns for 5 years | 74.69 | 48.81 | 153% |
| Returns for 10 years | 21.33 | N/A | - |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CHI | 9.74 | 0.15 | +1.56% |
| Calamos Convertible Opportunities and Income Fund | |||
| UIVM | 51.30 | 0.18 | +0.35% |
| VictoryShares International Val MomtETF | |||
| WBND | 20.08 | 0.06 | +0.32% |
| Western Asset Total Return ETF | |||
| AMUB | 20.46 | N/A | N/A |
| UBS ETRACS Alerian MLP ETN Series B | |||
| XBI | 78.16 | -2.94 | -3.63% |
| SPDR® S&P Biotech ETF | |||